Repeat Ultrasounds Predict Heart Risk
In High-Risk Patients, Repeating the Test Helped ID Those Who Had Heart Attacks, Strokes
Repeat Ultrasounds to Predict Heart, Stroke Risk continued...
"Our study is the first using repeat GSM testing for the assessment of
an individual's cardiovascular risk," Reiter says.
Next, the researchers looked at whether the GSM levels had decreased --
considered a bad sign, reflecting unstable plaque -- or increased (a neutral to
good sign) and whether the patient had had a cardiovascular event during the
follow-up, for a median of three years.
Over a follow-up of slightly more than three years, the GSM levels decreased
in 230 patients, or 40%, and increased in 344, or 60%. Those in the lowest GSM
group, with the darkest plaque, were about 1.7 times more likely to have a
cardiovascular event than those whose GSM went up the most, reflecting less
dense plaque, during the follow-up.
Those whose GSM declined the most had a 68% survival rate at three years,
compared to a 78% survival for those whose GSM increased.
The study is published in the September issue of the journal
Ultrasound Predicts Stroke, Heart Attack: Second Opinions
Evaluating plaque at a single time point "is not as predictive an
outcome as following it over time," says Nick Bryan, MD, a professor of
radiology at the University of Pennsylvania, Philadelphia, and a spokesman for
the American College of Radiology. That's a strength of the study, he says.
Another strength, he says: They used the ultrasound tests to predict
cardiovascular events anywhere in the body, not just in the carotid artery.
So would a repeat ultrasound have helped Russert?
Too soon to say, Bryan says. "We don't know how well this [finding about
repeat ultrasound] would apply to the general population," he says. In the
study, the average age was 72. "This is not ready for clinical
applications. It is a very interesting observation that will need a lot of
"There is a bias," agrees Pablo Abbona, MD, a radiologist at Santa
Monica-UCLA Medical Center & Orthopaedic Hospital in Santa Monica, Calif.
"The patients are all in a high-risk population."
Another expert, Ravi Dave, MD, a cardiologist at Santa Monica-UCLA Medical
Center & Orthopaedic Hospital and an associate professor of medicine at the
University of California, Los Angeles, pointed out that although ultrasound is
readily available, "not all labs have GSM."
Reiter agrees that more study is needed.
Lifestyle changes shouldn't be ignored, Dave says. "The current
aggressive treatment of patients at high risk should be continued," he
says. That means encouraging them to exercise if possible, eat a healthful
diet, and control blood pressure, blood sugar levels, and cholesterol.